Alterations in Redox System Parameters in Obsessive-Compulsive Disorder


Abstract views: 79 / PDF downloads: 42

Authors

DOI:

https://doi.org/10.62482/pmj.26

Keywords:

Obsessive-compulsive disorder, oxidative stress, antioxidant enzymes, lipid peroxidation

Abstract

Introduction: Obsessive-compulsive disorder (OCD) is a chronic neuropsychiatric condition characterized by intrusive obsessions and repetitive compulsions, significantly impairing daily functioning and the quality of life. Increasing evidence suggests that oxidative stress may play an important role in the pathophysiology of OCD, but the biochemical mechanisms underlying this relationship require further elaboration. This study aims to investigate the oxidant-antioxidant status in OCD patients compared to the healthy controls.

Methods: A total of 40 OCD patients diagnosed according to the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and 40 age- and sex-matched healthy controls were included in the study. Blood samples were collected from all the participants and a spectrophotometer was used to measure levels of lipid peroxidation (LPO), superoxide dismutase (SOD) activity, and glutathione S-transferase (GST).

Results: The results of our study showed that LPO levels increased (p≤0.0001) while SOD and GST activities decreased (p≤0.0001) in OCD patients when compared to the healthy controls. These findings suggest that oxidative stress imbalance may contribute to the neurobiological mechanisms of OCD, supporting the hypothesis that increased oxidative damage and impaired antioxidant defense systems are involved in the disorder’s pathophysiology of OCD.

Conclusions:. This study contributes to the growing literature on oxidative stress in psychiatric disorders and highlights the importance of investigating the biochemical pathways that may underline OCD pathogenesis. Understanding these biochemical alterations could provide valuable insights into the molecular basis of OCD and may led to the new approaches for potential therapeutic targets.

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association. 2013. https://doi.org/10.1176/appi.books.9780890425596

Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, van den Heuvel OA, Simpson HB. Obsessive–compulsive disorder. Nat Rev Dis Primers. 2019;5(1). https://doi.org/10.1038/s41572-019-0102-3

Goodman WK, Grice DE, Lapidus KAB, & Coffey BJ. Obsessive-compulsive disorder. In Psychiatr Clin North Am. 2014;37(3):257–267. https://doi.org/10.1016/j.psc.2014.06.004

Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010; 15(1): 53–63. https://doi.org/10.1038/mp.2008.94

Blanco-Vieira T, Radua J, Marcelino L, Bloch M, Mataix-Cols D, & do Rosário MC. The genetic epidemiology of obsessive-compulsive disorder: a systematic review and meta-analysis. Transl Psychiatry. 2023; 13(1): 230. https://doi.org/10.1038/s41398-023-02433-2

Bellia F, Vismara M, Annunzi E, Cifani C, Benatti, B, Dell’Osso B, & D’Addario C. Genetic and epigenetic architecture of Obsessive-Compulsive Disorder: In search of possible diagnostic and prognostic biomarkers. J Psychiatr Res. 2021;33: 554–571. https://doi.org/10.1016/j.jpsychires.2020.10.040

Pauls DL, Abramovitch A, Rauch SL, & Geller DA. Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15(6):410–424. https://doi.org/10.1038/nrn3746

Danışman Sonkurt M, Altınöz AE, Köşger F, Yiğitaslan S, Güleç G, & Eşsizoğlu A. Are there differences in oxidative stress and inflammatory processes between the autogenous and reactive subtypes of obsessive-compulsive disorder? A controlled cross-sectional study. Revista Brasileira de Psiquiatria. 2022; 44(2), 171–177. https://doi.org/10.1590/1516-4446-2021-1740

Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, Panda SK, Kerry RG, Duttaroy AK, Jena AB. Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications. Acta Pharmaceutica Sinica B. 2024. https://doi.org/10.1016/j.apsb.2024.10.004

Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol. 2011; 25(3): 287–299. https://doi.org/10.1016/j.bpobgyn.2010.10.016

Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res. 2010;68(4):261–275. https://doi.org/10.1016/j.neures.2010.08.007

Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, & Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J of Biochem Cell Biol. 2007; 39(1): 44–84. https://doi.org/10.1016/j.biocel.2006.07.001

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265-75. https://doi.org/10.1016/S0021-9258(19)52451-6

Yagi K. Assay for blood plasma or serum. Methods Enzymol. 1981;105: 328-37. https://doi.org/10.1016/S0076-6879(84)05042-4

Habig WH, Pabst MJ, & Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974; 249(22): 7130–9. https://doi.org/10.1016/S0021-9258(19)42083-8

Mylorie AA, Collins H, Umbles C, Kyle J. Erythrocyte SOD activity and other parameters of copper status in rats ingesting lead acetate. Toxicol Appl Pharmacol. 1986; 82: 512-20. https://doi.org/10.1016/0041-008X(86)90286-3

Ozdemir E, Cetinkaya S, Ersan S, Kucukosman S, Ersan EE. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1):62-5. https://doi.org/10.1016/j.pnpbp.2008.10.004

Jimenez-Fernandez S, Gurpegui M, Diaz-Atienza F, Perez-Costillas L, Gerstenberg M, Correll CU. Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis. J Clin Psychiatry. 2015;76(12):1658–67. https://doi.org/10.4088/JCP.14r09179

Liu T, Zhong S, Liao X, Chen J, He T, Lai S, Jia Y. A meta-analysis of oxidative stress markers in depression. PLoS One. 2015;10(10):0138904. https://doi.org/10.1371/journal.pone.0138904

Andreazza AC, Kauer-Sant’Anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 2008;111(2–3):135–44. https://doi.org/10.1016/j.jad.2008.04.013

Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 2014;218(1–2):61–8. https://doi.org/10.1016/j.psychres.2014.04.005

Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res. 2003;121(2):109–22. https://doi.org/10.1016/S0165-1781(03)00220-8

Talarowska M, Gałecki P, Maes M, Gardner A, Chamielec M, Orzechowska A, Bobińska K, Kowalczyk E. Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder. Mol Biol Rep. 2012;39(5):5359–66. https://doi.org/10.1016/S0165-1781(03)00220-8

Dean OM, den Buuse Mv, Bush A, Copolov D, Ng F, Dodd S, Berk M. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem. 2009;16(23):2965–76. https://doi.org/10.2174/092986709788803060

Brambilla F, Bellodi L, Perna G, Arancio C, Bertani A. Dopamine function in obsessive—compulsive disorder: Growth hormone response to apomorphine stimulation. Biol Psychiat. 1997;42(10):889–97. https://doi.org/10.1016/S0006-3223(96)00549-5

Taylor S. Disorder-specific genetic factors in obsessive-compulsive disorder: A comprehensive meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2016;171(3):325–32. https://doi.org/10.1002/ajmg.b.32407

Walitza S, Bové DS, Romanos M, Renner T, Held L, Simons M, Wewetzer C, Fleischhaker C, Remschmidt H, Warnke A. Pilot study on HTR2A promoter polymorphism,− 1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive–compulsive disorder. J Neural Transm. 2012;119(4):507–15. https://doi.org/10.1007/s00702-011-0699-1

Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review Eur. J. Med. Chem. 2015;97: 55-74. https://doi.org/10.1016/j.ejmech.2015.04.040

Dringen R, Gutterer JM, Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 2000; 267:4912-4916. https://doi.org/10.1046/j.1432-1327.2000.01597.x

Quadros VA, Rosa LV, Costa FV, Müller TE, Stefanello FV, Loro VL, Rosemberg DB. Involvement of anxiety-like behaviors and brain oxidative stress in the chronic effects of alarm reaction in zebrafish populations. Neurochem Int. 2019; 129:104488. https://doi.org/10.1016/j.neuint.2019.104488

Downloads

Published

2025-02-28

How to Cite

Akkus , E. I., Cansiz, D., Beler , M., Unal, I., Berfin Yildiz, J., Kocabasoglu, N., … Cengiz, M. (2025). Alterations in Redox System Parameters in Obsessive-Compulsive Disorder . Pharmedicine Journal, 2(1), 31–37. https://doi.org/10.62482/pmj.26

Issue

Section

Articles